Updated:
Biophy Capital Management
Biophy Capital Management uses machine learning to select hedge fund managers for institutional portfolios from its Philadelphia base.
Biophy Capital Management
Biophy Capital Management was established to apply quantitative machine-learning techniques to the fund-of-hedge-funds model. The firm is based in Philadelphia and builds concentrated portfolios on behalf of institutional clients. Its investment process explicitly uses alternative data and machine learning to evaluate hedge fund managers, seeking to identify persistent alpha-generating strategies before they become widely recognized by the broader allocator community. The firm's primary strategy is constructing multi-manager hedge fund portfolios. Biophy deploys capital across managers in equity long/short, credit, event-driven, and relative value strategies. The selection model is built around predictive algorithms that analyze manager performance attribution, factor exposures, and operational risk signals. The firm has stated that its machine-learning models are trained to identify early-stage, capacity-constrained managers. Geographic coverage is global, with a focus on North American and European managers. Biophy officially launched services to external institutional clients in 2024. The firm targets endowments, foundations, family offices, and pension funds seeking differentiated exposure to emerging hedge fund managers. The investment and technology teams are built with a blend of quantitative researchers and traditional allocator talent. The firm maintains its primary operations and research center in Philadelphia. Biophy's structural differentiator is its inversion of the traditional fund-of-funds sourcing funnel: rather than using qualitative meetings and consultant databases to narrow thousands of funds to a shortlist, its models first screen for quantitative signals of alpha persistence and capacity discipline, and only then does the team perform operational due diligence. This machine-first, human-second sequence is uncommon among institutional allocators and aims to reduce the behavioral biases inherent in manager selection.
General information
Firm type
Hedge Funds
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
Philadelphia, PA, United States
Sector focus
Frequently asked questions
How does Biophy Capital Management use artificial intelligence in its investment process?
Biophy deploys proprietary machine-learning models to perform the initial screening of hedge fund managers, evaluating quantitative attributes such as performance persistence, factor decomposition, and capacity analysis. This model identifies managers with attributes historically correlated with future alpha generation. The machine-first sequence is designed to surface high-conviction, often capacity-constrained managers that qualitative screens might overlook.
What types of hedge fund strategies does Biophy allocate to?
Biophy constructs portfolios spanning equity long/short, credit, event-driven, and relative value strategies. The firm seeks managers across the liquidity spectrum, including those running more concentrated or capacity-constrained books. Allocation decisions are driven by the output of its machine-learning models, which continuously reassess the opportunity set.
Who are Biophy Capital Management’s typical clients?
Biophy targets institutional limited partners including endowments, foundations, family offices, and pension funds. The firm officially launched services to external institutional investors in 2024, making it a relatively new allocator in the institutional fund-of-funds landscape.
Does Biophy Capital Management make direct investments or only invest in funds?
Biophy operates as a pure fund-of-funds manager, allocating capital to external hedge fund managers rather than making direct investments. This structure is designed to provide institutional clients with diversified, risk-managed access to a curated set of hedge fund strategies selected by its machine-learning platform.
What differentiates Biophy from a traditional fund of hedge funds?
The primary differentiator is Biophy's machine-first manager selection methodology. Most fund-of-funds platforms rely on a qualitative funnel of consultant databases, capital-introduction meetings, and in-person due diligence to build a pipeline — a process susceptible to behavioral biases. Biophy inverts this by running a quantitative, data-driven screen across a wide universe first, using alternative data and machine learning to identify managers with persistent alpha signals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: